Compare EQH & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EQH | RVTY |
|---|---|---|
| Founded | 1859 | 1937 |
| Country | United States | United States |
| Employees | 8000 | N/A |
| Industry | Specialty Insurers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 11.6B |
| IPO Year | N/A | 1994 |
| Metric | EQH | RVTY |
|---|---|---|
| Price | $51.53 | $114.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 16 |
| Target Price | $56.82 | ★ $109.67 |
| AVG Volume (30 Days) | ★ 2.9M | 1.5M |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.60% | 0.34% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.36 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $43.13 | $6.37 |
| Revenue Next Year | $7.45 | $5.10 |
| P/E Ratio | ★ N/A | $318.50 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $35.20 | $81.22 |
| 52 Week High | $55.24 | $118.30 |
| Indicator | EQH | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 68.83 | 56.46 |
| Support Level | $47.21 | $92.05 |
| Resistance Level | N/A | $116.82 |
| Average True Range (ATR) | 1.49 | 4.58 |
| MACD | 0.13 | -0.01 |
| Stochastic Oscillator | 95.56 | 79.14 |
Equitable Holdings Inc is a financial services company providing retirement, asset management, and wealth management solutions for individual and institutional clients, operating through three segments. The Retirement segment generates the majority of revenue and offers annuities, retirement savings plans, institutional savings products, and includes the spread lending business. The Asset Management segment provides diversified investment management and related services globally through Institutional, Retail, and Private Wealth channels and reflects the business of AB. The Wealth Management segment offers advisory accounts, financial planning and advice, life insurance, and annuity products. Revenues are earned predominantly from fee income, income from investments, and insurance premiums.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.